Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Says Ozempic to Be Eligible for US Price Negotiations in Less Than a Year
(Reuters) – Novo Nordisk’s blockbuster diabetes drug Ozempic will be eligible for U.S. government’s price negotiations in less than a year based on current criteria, the Danish drugmaker’s CEO Lars Fruergaard Jorgensen said in his written testimony on Monday. Jorgensen…
English